日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy

利用80基因和70基因特征对HER2阳性患者进行基因组分类,揭示了HER2靶向新辅助治疗临床结果的差异

Whitworth, Pat W; Beitsch, Peter D; Murray, Mary K; Richards, Paul D; Mislowsky, Angela; Dul, Carrie L; Pellicane, James V; Baron, Paul L; Rahman, Rakhshanda Layeequr; Lee, Laura A; Dupree, Beth B; Kelemen, Pond R; Ashikari, Andrew Y; Budway, Raye J; Lopez-Penalver, Cristina; Dooley, William; Wang, Shiyu; Dauer, Patricia; Menicucci, Andrea R; Yoder, Erin B; Finn, Christine; Blumencranz, Lisa E; Audeh, William

Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping

前瞻性新辅助乳腺登记交响曲试验(NBRST)中临床管腔型乳腺癌患者的化疗敏感性和内分泌敏感性通过分子分型预测

Whitworth, Pat; Beitsch, Peter; Mislowsky, Angela; Pellicane, James V; Nash, Charles; Murray, Mary; Lee, Laura A; Dul, Carrie L; Rotkis, Michael; Baron, Paul; Stork-Sloots, Lisette; de Snoo, Femke A; Beatty, Jennifer

Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy

肿瘤大小对新辅助化疗后病理完全缓解概率的影响

Baron, Paul; Beitsch, Peter; Boselli, Danielle; Symanowski, James; Pellicane, James V; Beatty, Jennifer; Richards, Paul; Mislowsky, Angela; Nash, Charles; Lee, Laura A; Murray, Mary; de Snoo, Femke A; Stork-Sloots, Lisette; Gittleman, Mark; Akbari, Stephanie; Whitworth, Pat

Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

在前瞻性新辅助乳腺癌登记交响曲试验 (NBRST) 中,BluePrint 80 基因功能亚型和 MammaPrint 预测化疗敏感性

Whitworth, Pat; Stork-Sloots, Lisette; de Snoo, Femke A; Richards, Paul; Rotkis, Michael; Beatty, Jennifer; Mislowsky, Angela; Pellicane, James V; Nguyen, Bichlien; Lee, Laura; Nash, Charles; Gittleman, Mark; Akbari, Stephanie; Beitsch, Peter D